Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Emcure Pharma IPO and Tracxn Technologies IPO.
Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tracxn Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Emcure Pharma IPO | Tracxn Technologies IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Iifl Securities Ltd |
| Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
|
| Anchor Investor | Anchor Investor |
|
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Emcure Pharma IPO is whereas the issue size of the Tracxn Technologies IPO is up to ₹309.38 Cr. The final issue price of Emcure Pharma IPO is and of Tracxn Technologies IPO is ₹80.00 per share.
| Emcure Pharma IPO | Tracxn Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹75.00 per share | |
| Issue Price (Upper) | ₹80.00 per share | |
| Issue Price (Final) | ₹80.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 185 shares | |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | up to ₹800.00 Cr | |
| OFS Issue Size | 1,36,78,839 shares | 3,86,72,208 shares |
| OFS Issue Size (Amount) | up to ₹309.38 Cr | |
| Issue Size Total | 3,86,72,208 shares | |
| Issue Size Total (Amount) | up to ₹309.38 Cr |
Emcure Pharma IPO opens on , while Tracxn Technologies IPO opens on Oct 10, 2022. The closing date of Emcure Pharma IPO and Tracxn Technologies IPO is , and Oct 12, 2022, respectively.
| Emcure Pharma IPO | Tracxn Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 10, 2022 | |
| Issue Close | Oct 12, 2022 | |
| Basis Of Allotment (Tentative) | Oct 17, 2022 | |
| Initiation of Refunds (Tentative) | Oct 18, 2022 | |
| Credit of Share (Tentative) | Oct 19, 2022 | |
| Listing date (Tentative) | Oct 20, 2022 | |
| Anchor Lockin End date 1 | Nov 16, 2022 | |
| Anchor Lockin End date 2 | Jan 15, 2023 |
Emcure Pharma IPO P/E ratio is , as compared to Tracxn Technologies IPO P/E ratio of 240.
| Emcure Pharma IPO | Tracxn Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 50.93% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 35.65% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 240 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹802.48 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Emcure Pharma IPO retail investors (RII) are offered while in Tracxn Technologies IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Emcure Pharma IPO and 1,16,01,663 shares in Tracxn Technologies IPO.
| Emcure Pharma IPO | Tracxn Technologies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 1,16,01,663 shares | |
| NII | 58,00,831 shares | |
| RII | 38,67,220 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 2,12,69,714 shares |
Emcure Pharma IPO subscribed in total, whereas Tracxn Technologies IPO subscribed 2.01x.
| Emcure Pharma IPO | Tracxn Technologies IPO | |
|---|---|---|
| QIB (times) | 1.66x | |
| NII (times) | 0.80x | |
| Big NII (times) | 0.72x | |
| Small NII (times) | 0.94x | |
| RII (times) | 4.87x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.01x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
